共 32 条
- [21] Relapse in patients with schizophrenia and amisulpride-induced hyperprolactinemia or olanzapine-induced metabolic disturbance after switching to other antipsychoticsPSYCHIATRY RESEARCH, 2023, 322Cai, JingdaLi, LiShao, TiannanSun, MengxiWang, WeiyanXie, PengWang, XiaoyiYang, YeLong, YujunKang, DongyuXiao, JingmeiSu, YuhanPeng, XingjieHuang, YuyanGao, MenghuiWu, QiongqiongSong, ChuhanLiu, FuruShao, PingOu, JianjunShen, YidongHuang, JingWu, Renrong
- [22] The Efficacy and Safety of Switching to Ziprasidone from Olanzapine in Patients with Bipolar I Disorder: An 8-Week, Multicenter, Open-Label StudyClinical Drug Investigation, 2013, 33 : 743 - 753Hwang-Bin LeeBo-Hyun YoonYoung-Joon KwonYoung Sup WooJung-Goo LeeMoon-Doo KimWon-Myong Bahk
- [23] Switching patients from olanzapine or risperidone to a combination treatment using perphenazine plus buspirone: Evaluation of antipsychotic efficacy and side-effects, including extrapyramidal effects and weight lossNORDIC JOURNAL OF PSYCHIATRY, 2005, 59 (03) : 205 - 208Andersen, THBech, PLarsen, NE
- [24] Study on Metabolic Parameters in Obese Patients Compared to Normal Weight Subjects Before and After Joint Replacement SurgeryREVISTA DE CHIMIE, 2018, 69 (04): : 944 - 947Tilinca, Mariana CorneliaVoidazan, SeptimiuNyulas, KingaTilinca, Raluca MariaNagy, Eniko Nemes
- [25] Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trialsJOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 (07) : 1019 - 1029Kane, John M.Barnes, Thomas R. E.Correll, Christoph U.Sachs, GaryBuckley, PeterEudicone, JamesMcQuade, RobertTran, Quynh-VanPikalov, Andrei, IIIAssuncao-Talbott, Sheila
- [26] Evaluation of the efficacy of an antioxidant combination for the modulation of metabolic, endocrine, and clinical parameters in patients with polycystic ovary syndromeGYNECOLOGICAL ENDOCRINOLOGY, 2023, 39 (01)Santofimia, Carmen PingarronPoyo Torcal, SilviaLopez Verdu, HelenaHenriquez Linares, AlexandraCalvente Aguilar, VirginiaTerol Sanchez, PabloMartinez Garcia, Maria SolLafuente Gonzalez, Pilar
- [27] Factors associated with weight gain during olanzapine treatment in patients with schizophrenia or bipolar disorder: Results from a six-month prospective, multinational, observational studyWORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2009, 10 (04) : 729 - 740Treuer, TamasHoffmann, Vicki PooleChen, Antony Kuang-PengIrimia, VictoriaOcampo, MagdalenaWang, GangSingh, PritibhaHolt, Susanna
- [28] Predictive Value of Early Changes in Triglycerides and Weight for Longer-Term Changes in Metabolic Measures During Olanzapine, Ziprasidone or Aripiprazole Treatment for Schizophrenia and Schizoaffective Disorder Post Hoc Analyses of 3 Randomized, Controlled Clinical TrialsJOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 30 (06) : 656 - 660Hoffmann, Vicki P.Case, MichaelStauffer, Virginia L.Jacobson, Jennie G.Conley, Robert R.
- [29] Changes in metabolic parameters and body weight in brexpiprazole-treated patients with acute schizophrenia: pooled analyses of phase 3 clinical studiesCURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (12) : 2197 - 2205Newcomer, John W.Eriksson, HansZhang, PeterWeiller, EmmanuelleWeiss, Catherine
- [30] Metabolic and body mass parameters after treatment with JNJ-37822681, a novel fast-dissociating D2 receptor antagonist, vs olanzapine in patients with schizophreniaANNALS OF CLINICAL PSYCHIATRY, 2013, 25 (03) : 173 - 183Daly, Ella J.Kent, Justine M.Janssens, LucNewcomer, John W.Husken, GittaDe Boer, PeterTritsmans, LucSchmidt, Mark E.